Members of the tripartite motif (TRIM) family of E3 ubiquitin ligases regulate immune pathways 26 including the antiviral type I interferon (IFN-I) system. Previously, we demonstrated that TRIM6 is 27 involved in IFN-I induction and signaling. In absence of TRIM6 function, optimal IFN-I signaling is 28 reduced, allowing increased replication of interferon-sensitive viruses. Despite numerous 29 mechanisms to restrict vertebrate host's IFN-I response, West Nile Virus (WNV) replication is 30 sensitive to pre-treatment with IFN-I. However, the regulators and products of the IFN-I pathway 31
areas throughout the world. Infection with WNV results in febrile illness, which can progress to severe 48 neurological disease. Currently, there are no approved treatment options to control WNV infection. 49
Understanding the cellular immune responses that regulate viral replication is important in diversifying 50 the resources available to control WNV. Here we show that the elimination of TRIM6 in human cells 51 results in an increase in WNV replication and alters the expression and function of other components 52 of the IFN-I pathway through VAMP8. Dissecting the interactions between WNV and host defenses 53 both informs basic molecular virology and promotes the development of host-and viral-targeted 54 antiviral strategies. 55
INTRODUCTION 57
West Nile Virus (WNV) is an enveloped positive sense single stranded RNA virus and a member of 58 the family Flaviviridae (1, 2) . Mosquitoes competent for WNV (predominantly Culex) transmit the virus 59 through blood feeding. Enzootic transmission cycles between birds and mosquitoes maintain the virus 60 in the environment, but mosquitoes also incidentally infect humans and other mammals that act as 61 dead-end hosts. In 1999, WNV was introduced to North America and has since then become an 62 endemic pathogen, causing annual outbreaks in human populations, and is the leading cause of 63 mosquito-borne encephalitis (3) . Although primarily asymptomatic, WNV infection causes flu-like 64 symptoms in approximately 20% of infected humans with fewer than 1% of symptomatic cases 65 progressing to neurologic manifestations (4) . The case fatality rate for symptomatic cases is 66 approximately 10% (1) . Currently, no WNV vaccines or anti-viral treatments are approved for human 67 use (5) (6) (7) (8) (9) . 68
Understanding the molecular mechanisms of WNV replication at the host cellular level, and 69 specifically WNV-host IFN-I interactions, may allow identifying targets for antiviral development. Many 70 groups have demonstrated that interferon-stimulated gene (ISG) products, such as ISG54 (IFIT2) 71 (10), IFITM3 (11), and Oas1b (12), and others (Reviewed in: (13)) restrict WNV replication. Further, in 72 mouse models of WNV infection, lack of IFN-I induction through signaling factors such as TLR3 (14, 73 15), IRF7 (14), RIG-I (16) , IFNβ (2, 17) , IFNAR (14), STAT1 (18) , and IKKε (10) increases 74 susceptibility to WNV. Mutations in IFN-I pathway genes and ISGs have also been associated with 75 increased disease during WNV infections in humans (19, 20) . Despite WNV's sensitivity to 76 WNV has evolved several mechanisms to antagonize IFN-I including NS1 interference with RIG-I and 77 MDA5 (21) , NS3 helicase impairment of Oas1b activity (12), NS5 disruption of the type-I interferon 78 receptor (IFNAR) surface expression (22) , STAT1 phosphorylation (23) , and subgenomic flavivirus 79 RNA (24). Since WNV's resistance to IFN-I contributes to virulence (14, 25), defining the IFN-I signaling pathway components required to respond to WNV infection is important in aiding the 81 development of WNV-specific therapies. 82
Upon WNV infection, pathogen recognition receptors including RIG-I and MDA5 recognize viral RNA 83 (16) and signal through their adaptor MAVS to activate downstream IKK-like kinases TBK1 and IKKε. 84
Activation of TBK1 and IKKε promote IFN-I production through activation of transcription factors IRF3 85 and IRF7 (26). IFN-I is then secreted and engages the IFN-I receptor to induce IFN-I signaling. Early 86 in the IFN-I signaling cascade, the kinases Jak1 and Tyk2 phosphorylate STAT1 (Y701) and STAT2 87 (Y690), which dimerize and interact with IRF9 to form the ISGF3 complex (27, 28). ISGF3 interacts 88 with interferon-stimulated response element (ISRE) present in the promoter of ISGs. In addition, upon 89 IFN-I stimulation, IKKε plays an essential role in phosphorylation of STAT1 on S708, which is 90 required for induction of IKKε-dependent ISGs leading to an optimal antiviral response (29). Several 91
IKKε-dependent ISGs, including ISG54, are involved in restricting WNV (10). 92 TRIM6, an E3 ubiquitin ligase in the tripartite motif (TRIM) protein family, plays a crucial role in 93 facilitating the activation of the IKKε-dependent branch of the IFN-I signaling pathway. In concert with 94 the ubiquitin activating (E1) and the E2 ubiquitin conjugating enzyme UbE2K, TRIM6 synthesizes 95 unanchored K48-linked polyubiquitin chains that promote the oligomerization and 96 autophosphorylation of IKKε (T501) (30). Following phosphorylation of T501, IKKε is activated and 97 phosphorylates STAT1 (S708) to promote the transcription of the IKKε-dependent ISGs (30). Due to 98 TRIM6's role in activating IKKε-dependent IFN-I signaling and the importance of IKKε-specific ISGs in 99 restricting WNV, we hypothesized that WNV replication would be enhanced in the absence of TRIM6.
100 Here we show that WNV viral load is increased and that IFN-I induction and IKKε-dependent IFN-I 101 signaling are impaired in TRIM6-knockout (TRIM6-KO) cells. Next-generation RNA sequencing 102 (NGS) identified several ISGs expressed at lower levels in TRIM6-KO cells compared to wild-type 103 (wt) cells, as well as several ISGs differentially expressed in TRIM6-KO cells previously described to 104 restrict WNV replication. We investigated the role of a TRIM6-dependent gene not previously 105 described to regulate WNV replication or IFN-I signaling, Vamp8. VAMP8 is a vesicle-associated-106 membrane protein in the SNARE (Soluble-N-ethylmaleimide-sensitive factor attachment protein) 107 family known to modulate endocytosis (31), exocytosis of secretory (32-35) and lytic (36) granules, 108 thymus development (37) , receptor exocytosis (38) , and cross-presentation by antigen presenting 109 cells (39) . We found that VAMP8 did not directly affect WNV replication, but does promote optimal 110 IFN-I signaling. Overall, we conclude that TRIM6 is important in promoting optimal IFN-I induction and 111 signaling during WNV infection and that VAMP8 is a novel TRIM6-dependent factor involved in 112 regulating IFN-I signaling.
113 114 RESULTS
115

WNV Replication is Increased in IFN-I Induction and Signaling Impaired TRIM6-KO Cells
116 To test our hypothesis that the absence of TRIM6 facilitates WNV replication, growth kinetics at a MoI 117 of 0.1 were determined in wt and TRIM6-KO A549 cells, respectively. A significant increase in viral 118 replication was detected in TRIM6-KO cells at 48 hours post infection (hpi) in comparison to wt cells 119 ( Figure 1A) . To address the effect of the absence of TRIM6 on the IFN-I pathway, protein expression 120 and phosphorylation of IFN-I pathway components in WNV infected cells were assessed ( Figure 1B ). 121 No differences in the levels of TBK1 phosphorylation or total TBK1 expression were detected 122 between wt and TRIM6-KO cells ( Figure 1B ). While the levels of pIKKε (S172), a TRIM6-independnet 123 post-translational modification, were not significantly different between wt and TRIM6-KO cells, the 124 TRIM6-dependent phosphorylation on IKKε (T501) was substantially lower in the TRIM6-KO cells 125 ( Figure 1B) , consistent with our previous reports that TRIM6 is important for IKKε activation (30). In 126 line with these findings, IRF3 phosphorylation, a marker of IFNβ induction, was also reduced in 127 TRIM6-KO cells ( Figure 1B ). Although these results suggest that there is reduced IFN-I induction in 128 TRIM6-KO cells, STAT1 (Y701) phosphorylation (IKKε and TRIM6-independent (29, 30)) was not 129 significantly affected, suggesting that there is enough IFN-I induced during WNV infection. To further 130 characterize IFN-I signaling in TRIM6-KO cells, RNA expression levels for ifnB and selected ISGs 131 were analyzed ( Figure 1C ). Indeed, ifnb mRNA is reduced in TRIM6-KO cells only at early time points 132 p.i. and is later significantly increased as compared to wt cells ( Figure 1C ). The amount of total 133 STAT1 protein, which is itself an IKKε-independent ISG (29), is substantially increased in TRIM6-KO 134 relative to wt cells at the later time points (48-72 hp.i., Figure 1B ), consistent with the higher levels of 135 ifnb mRNA observed in TRIM6-KO cells ( Figure 1C ). The high levels of ifnb mRNA observed at 48 hpi 136 in TRIM6-KO cells ( Figure 1C ) are probably due to the increased viral replication, and possible 137 redundancy of other TRIM6/IKKε-independent pathways in IFN-I induction. Increased total STAT1 in 138 TRIM6-KO cells is also consistent with the reported accumulation of unphosphorylated STAT1 in 139 IKKε-KO cells (40) . However, phosphorylation on STAT1 (S708), an IKKε and TRIM6-dependent 140 modification (29, 30), is nearly undetectable in the TRIM6-KO cells upon WNV infection ( Figure 1B ).
141 Consistent with this defect in the TRIM6-IKKε branch of the IFN-I signaling pathway in TRIM6-KO 142 cells, the TRIM6/IKKε-dependent ISGs Isg54 and Oas1 (29, 30), have different patterns of induction.
143 In the case of Isg54, induction is significantly lower in the TRIM6-KO cells than in wt cells at 24 hpi, 144 but this pattern is reversed at 72 hpi mirroring Ifnb expression ( Figure 1C ). In contrast, induction of 145 Oas1 is attenuated in TRIM6-KO cells 24-72 hpi ( Figure 1C ). IKKε-independent ISGs Irf7 and Stat1 146 and non-ISG Il-6 are expressed at higher levels in TRIM6-KO cells at later time points ( Figure 1C ), 147 again in correlation with Ifnb induction. Overall, the absence of TRIM6 augments WNV replication and 148 impairs the IKKε-dependent branch of the IFN-I pathway, in line with our previous findings with other 149 viruses including Influenza, Sendai and Encephalomyocarditis (30).
150 151 152
IFN-I has reduced anti-WNV activity in TRIM6-deficient cells 153
Next, we sought to evaluate further the impact of TRIM6 on the antiviral efficiency of IFN-I against 154 WNV. Prior to infection, wt and TRIM6-KO A549 cells were treated with 100U of recombinant human 155 IFNβ for 4 hours prior to infection with WNV (MoI 5.0) for 24 hours (Figure 2 ). Pre-treatment with IFNβ 156 decreased viral load in both wt and TRIM6-KO cells, however IFN-I pre-treatment was significantly 157 less effective in inhibiting WNV replication in TRIM6-KO (40 fold) as compared to wt controls (63 158 fold). As expected, this result indicates that IFN-I signaling is suboptimal in the absence of TRIM6, 159 enabling WNV to replicate to higher titers, and suggests that expression of TRIM6-dependent ISGs 160 may be involved in establishing an optimal IFN-I mediated anti-WNV response.
161 162 VAMP8 is induced in a TRIM6-dependent manner
163
To identify other genes affected as a consequence of TRIM6's absence, next generation sequencing 164 (NGS) of mock ( Figure 3A ) and WNV-infected ( Figure 3B ) wt and TRIM6-KO cells was performed.
165 During WNV infection, canonical ISGs were identified as being expressed at lower levels in the 166 TRIM6-KO compared to wt cells, which validates the methodology ( Figure 3B ). Several canonical 167 ISGs down-regulated in TRIM6-KO cells have previously been described to antagonize WNV 168 replication, including Ifitm2 (41) and -3 (11), or their loss of function is associated with increased WNV 169 susceptibility, including Mx1 and OasL (42) . We elected to investigate other genes not previously 170 described to regulate WNV replication or IFN-I pathways. A strongly downregulated gene in both 171 mock and infected cells, VAMP8, was chosen as a target for further mechanistic validation ( Figure  172  3A) . 173 After confirming that VAMP8 was expressed lower at the translational ( Figure 3C ) and transcriptional 174 ( Figure 3D ) levels in TRIM6-KO cells, the role of VAMP8 in regulating WNV replication was 175 interrogated. Therefore, wt A549 cells were transfected with a VAMP8-targeting siRNA pool or non-176 targeting control siRNA (ntc) for 24 hours prior to WNV infection (MoI 0.1). VAMP8 knockdown (kd) 177 had no measurable effect on WNV replication ( Figure 4A ). VAMP8-kd was validated by western blot, 178 showing undetectable levels of protein, with a clear upregulation in VAMP8 protein by 24 hpi in ntc 179 transfected cells ( Figure 4B ). Phosphorylation of IRF3 in VAMP8-kd cells was not significantly 180 affected as compared to ntc-kd cells, suggesting there is no defect in IFN-I induction ( Figure 4B ). In 181 contrast, phosphorylated STAT1 (Y701) was significantly lower in the VAMP8-kd cells at 48 and 72 182 hpi, suggesting impairment in IFN-I signaling ( Figure 4B ).
183 Subsequently, to examine whether VAMP8 is involved in regulation of the IFN-I signaling pathway, wt 184 A549 cells were transfected with VAMP8-targeting or ntc siRNAs for 24 hours and treated with IFNβ 185 for 12 hours. As expected, total STAT1 was induced in both VAMP8-and ntc-kd cells following IFNβ 186 stimulation, but the level of total STAT1 in VAMP8-kd cells was slightly attenuated ( Figure 5A ). 187 VAMP8's effect on STAT1 activation is more evident; however, with a strong reduction in the amount 188 of pSTAT1 (Y701) ( Figure 5A ). Consistent with a potential role of VAMP8 in regulating STAT1 189 phosphorylation, mRNA expression levels upon IFNβ treatment of ISGs including Stat1, Isg54, and 190 Oas1 was significantly reduced in VAMP8-kd as compared to controls ( Figure 5B ). Overall, the above 191 evidence supports that 1) VAMP8 expression is TRIM6-mediated, 2) VAMP8 does not directly affect 192 WNV replication, and 3) VAMP8 is involved in positive regulation of IFN-I signaling upstream of 193 STAT1 phosphorylation.
195 VAMP8 Knockdown Enhances WNV Replication in Cells Pre-treated with Type I IFN
196
Since VAMP8 modulates the IFN-I system, but does not appear to alter WNV replication, we 197 examined whether exogenous IFN-I pre-treatment would reveal a functional defect in IFN-I signaling 198 in VAMP8-kd cells during WNV infection. Prior to infection, wt A549 cells were treated with siRNA 199 (VAMP8 or ntc) for 24 hours followed by a 16-hour treatment with IFNβ. Although IFNβ pre-treatment 200 reduced viral production in both groups, IFNβ treatment was less efficient in protecting VAMP8-kd 201 cells against WNV replication as compared to ntc (ntc siRNA: 508 fold; VAMP8 siRNA: 79 fold) 202 ( Figure 6 ). As opposed to previous experiments showing no impact on WNV replication following 203 VAMP8-kd, the combination of IFN-β pre-treatment and VAMP8 siRNA showed an 8-fold increase in 204 the replication of WNV over cells treated with ntc siRNA and IFNβ. This result suggests that VAMP8 205 plays a functional role in IFN-I signaling during WNV infection.
206 207 DISCUSSION
208
Our study demonstrates the relevance of TRIM6 in regulating the IFN-I pathway during WNV infection 209 and identifies VAMP8 as a factor functionally involved in IFN-I signaling. Extensive research has 210 implicated the TRIM family of proteins in both regulation of the innate immune response and the 211 restriction of viral replication (30, [43] [44] [45] [46] [47] [48] . Specifically, TRIM6 has been shown to facilitate the 212 formation of unanchored K48-linked polyubiquitin chains that provide a scaffold for IKKε homo-213 oligomerization, ultimately resulting in IKKε activation and STAT1 phosphorylation at S708 (30).
214 Phosphorylation of STAT1 at S708 is important to sustain IFN-I signaling and to express a unique 215 subset of ISGs (29, 40) . The relevance of IKKε-dependent gene expression has previously been 216 described for WNV, and in the absence of ISG54 or IKKε mice have an increased susceptibility (10).
217 These experiments served as a rationale for exploring the functional role of TRIM6 during WNV 218 infection. 219 As expected, we observed an increase in WNV replication in TRIM6-KO cells in parallel with 220 attenuated TRIM6-dependent activation of IKKε (T501 phosphorylation), IKKε-dependent STAT1 221 S708 phosphorylation, and IKKε-dependent gene expression. There was impaired Ifnb and Isg54 222 mRNA induction in TRIM6-KO cells at 6 and 24 hpi, respectively, but higher levels of induction at 72 223 hpi. The transient effect of TRIM6 on the IFN-I pathway may be due to the increased amount of virus 224 at the peak of infection resulting in more cells producing IFN-I to compensate for TRIM6 deficiency. 225 Although no other factor has been shown to synthesize the unanchored K48-polyubiquitin chains 226 required for IKKε activation, we cannot exclude that other TRIM members or other E3-Ub ligases may 227 compensate for the loss of TRIM6. Alternatively, TRIM6 may play important roles in other pathways 228 (i.e. NF-ĸB), resulting in cytokine dysregulation and/or induction of IFNβ by TRIM6-independent 229 pathways. Furthermore, since no difference in TBK1 phosphorylation is observed between wt and 230 TRIM6-KO cells, it is possible that TBK1 activation is sufficient to compensate for reduced IKKε 231 activation in the IFN production pathway. Further emergent WNV strains encode a functional 2-O 232 methylase in their non-structural protein 5 that prohibits IFIT proteins, specifically murine ISG54 and 233 human ISG58, from suppressing viral mRNA expression (49) . Since WNV antagonizes components 234 of this pathway, we cannot rule out the possibility that WNV proteins target TRIM6 to impede IKKε-235 dependent expression of WNV-restricting ISGs. For example, the matrix protein of Nipah virus (family 236 Paramyxoviridae) works to promote the degradation of TRIM6 during viral infection to promote viral 237 replication through impaired IKKε signaling and thus a blunted IFN-I response (44) . WNV protein 238 antagonism of TRIM6 could also preclude observing more severe differences in WNV replication 239 between wt and TRIM6-KO cells. Alternatively, TRIM6 could play an essential role in IKKε-dependent 240 signaling but could also be hijacked by a virus to facilitate viral replication. In a previous study, we 241 showed that TRIM6 directly promotes the replication of ebolavirus (family Filoviridae) through 242 interactions with VP35 and that VP35 antagonizes TRIM6's capacity to promote IFN-I signaling (43) .
243 Although we identified several ISGs differentially expressed in TRIM6-KO compared to wt cells 244 following WNV infection, we also identified Vamp8 to be significantly down-regulated under both 245 basal conditions and WNV infection. VAMP8 has not been previously described to affect WNV 246 replication or the IFN-I pathway. Although its role was not described, VAMP8 had been identified as 247 an antiviral factor in an siRNA screen for Japanese encephalitis virus (JEV), another mosquito-borne 248 flavivirus (50) . Here we showed, in contrast to that seen with JEV, VAMP8-kd does not directly affect 249 WNV replication. The impairment of STAT1 Y701 phosphorylation during WNV in the VAMP8-kd cells 250 lent evidence that VAMP8 could be involved in IFN-I signaling. Since WNV efficiently impairs IFN-I 34, 36) . Potential mechanisms of the IFN-I 262 pathway, which VAMP8 may regulate, include surface expression of the IFNAR receptor or recycling 263 of receptor components to the plasma membrane. VAMP8 has been described to regulate the 264 surface expression of a water transport channel, aquaporin 2, in the kidney (38) . Despite the reduced 265 surface expression, the total amount of aquaporin 2 is higher in the cell, but it is retained in vesicles 266 below the plasma membrane (38) . Alternatively, VAMP8 might influence the secretion of factors or 267 the oxidative condition of the microenvironment important to maintain IFN-I signaling. In phagocytic 268 cells infected with Leishmania, VAMP8 regulates the transport of NADPH oxidase to the phagosome 269 to facilitate optimal conditions for peptide loading into MHC class I molecules (39) . Although VAMP8 270 would not be regulating phagocytosis in this model of WNV infection, it is possible that VAMP8 271 regulates NADPH oxidase localization affecting the oxidative environment of the infected cell and 272 consequently IFN-I signaling (51) (52) (53) . TRIM6 may either directly affect VAMP8 expression or may act 273 indirectly through a yet unidentified secondary factor. Dissecting this interaction will be important in 274 further understanding TRIM6's regulation of the host's IFN-I pathway and uncovering VAMP8's novel 275 role in IFN-I signaling. Our study indicates a new role for VAMP8 in the TRIM6 pathway of immune 276 activation during viral infection (Figure 7) .
277 Elucidating the interactions of the human immune system with viral infection is essential to 278 understanding viral pathology, as well as identifying cellular targets for antiviral drug development.
279 Our work has identified a novel IFN related host factor that is important in the regulation of WNV 
292
Viruses & Cells: West Nile Virus (WNV) isolate 385-99 was obtained from the World Reference 293 Center for Emerging Viruses & Arboviruses (UTMB, Dr. Robert Tesh). A549 and CCL-81 lines were 294 obtained from the American Type Culture Collection. TRIM6 knockout cells were prepared as 295 previously described (43) . All lines were maintained in DMEM (Gibco), supplemented with 10% Fetal 296
Bovine Serum (Atlanta Biologicals). Infections were performed in DMEM supplemented with 2% Fetal 297 Bovine Serum (FBS), and 1% Penicillin/Streptomycin (Gibco). For growth kinetics experiments, 298 150,000 wt or TRIM6-KO A549 cells/well were infected with 100μL of WNV multiplicity of infection 299 (MoI) 0.1 or 5.0 for 1 hour at 37°C, 5% CO2 then the inoculum was removed and washed 3 times with 300 1mL of 1X PBS. After the cells were washed, 1mL of DMEM supplemented with 2% FBS was added 301 to each well. Supernatant (150μL) was collected at the designated time points for plaque assay.
302 Plaque assays were performed in 12-well plates containing 200,000 CCL-81 cells/well. Viral samples 303 were diluted log fold and applied to the monolayer. Following provided read counts per gene, which were input into the DESeq2 (version 1.12.1) (55) differential 344 expression analysis program to determine expression levels and differentially expressed genes. (1:2000) , anti-total STAT1 (1:1000) (BD Biosciences), anti-360 VAMP8 (Cell Signaling) (1:500), anti-IKKε (T501) (1:1000) (Novus Biologicals), anti-IKKε (S172) 361 (1:1000), anti-total IKKε (1:1000) (Abcam), anti-pTBK1 (S172) (1:1000) (Epitomics), anti-total TBK1 362 (1:1000) (Novus Biologicals). Immunoblots were developed with the following secondary antibodies: 363 ECL anti-rabbit IgG horseradish peroxidase conjugated whole antibody from donkey (1:10,000 
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Following virus infection, viral RNA is recognized by pathogen recognition receptors (PRRs). PRRs 575 then signal through their adaptors, triggering the activation of kinases TBK1 and IKKε, which 576 phosphorylate and activate the transcription factor IRF3. Once activated, IRF3 translocates to the 577 nucleus and, in concert with other factors not indicated, promotes the transcription of IFNβ. IFNβ is 578 then secreted and signals in an autocrine or paracrine manner through the type I IFN receptor 579 (IFNAR). The kinases (Jak1 and Tyk2) associated with IFNAR then facilitate the phosphorylation of 580 STAT1 at tyrosine (Y) 701 and STAT2 in an IKKε-independent manner. Phosphorylated STAT1 and 581 STAT2 interact with IRF9 to form the ISGF3 complex, which translocates to the nucleus to promote 582 the transcription of genes with interferon stimulated response elements (ISRE) including Stat1, Oas1, 583 and Isg54. In addition to IKKε independent IFN-I signaling, the E3 ubiquitin ligase TRIM6 facilitates 584 IKKε-dependent IFN-I signaling. TRIM6, in coordination with the ubiquitin activating (UbE1) and 585 ligating (UbE2K) enzymes to facilitate the formation of K48-linked unanchored poly-ubiquitin chains, 586 which act as a scaffold for the oligomerization and cross-phosphorylation of IKKε at threonine (T) 587 501(30). TRIM6 also facilitates activation of IKKε during IFN-I induction. During IFN-I signaling, 588 activated IKKε phosphorylates STAT1 at serine (S) 708. STAT1 phosphorylation at S708, an IKKε-589 dependent modification, facilitates the formation of an ISGF3 complex with different biophysiological 590 properties which allows the ISGF3 complex to have enhanced binding to certain ISRE-containing 591 promoters ultimately inducing a different ISG profile than when STAT1 is phosphorylated at Y701 (29, 592 40). Although the mechanism is currently unknown (question mark), TRIM6 induces VAMP8 593 expression, which in turn is important for inducing optimal IFN-I signaling modulating STAT1 594 phosphorylation at Y701, and an efficient antiviral response. 595 596 Table S1 . qRT-PCR primers 
